Clinical Trial Update: Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial of grass pollen immunotherapy using a cluster regime for seasonal rhinitis and asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Seasonal Allergic Rhinitis

Drugs mentioned

• Grass pollen immunotherapy (cluster regime)

Snippet

Sponsor: Imperial College London | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED